Potential impact of GLP-1 receptor agonists on male fertility: a fable of caution.
作者信息
Du Plessis Stefan S, Omolaoye Temidayo S, Cardona Maya Walter D
机构信息
College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Dubai, United Arab Emirates.
Reproduction Group, Department of Microbiology and Parasitology, Faculty of Medicine, Universidad de Antioquia, Medellín, Colombia.
出版信息
Front Physiol. 2024 Nov 18;15:1496416. doi: 10.3389/fphys.2024.1496416. eCollection 2024.
Abstract
摘要
相似文献
1
Potential impact of GLP-1 receptor agonists on male fertility: a fable of caution.胰高血糖素样肽-1受体激动剂对男性生育能力的潜在影响：一则警示故事。
Front Physiol. 2024 Nov 18;15:1496416. doi: 10.3389/fphys.2024.1496416. eCollection 2024.
2
Impact of GLP-1 Agonists on Male Reproductive Health-A Narrative Review.GLP-1 激动剂对男性生殖健康的影响——一篇叙述性综述。
Medicina (Kaunas). 2023 Dec 27;60(1):50. doi: 10.3390/medicina60010050.
3
The role of glucagon-like peptide-1 in reproduction: from physiology to therapeutic perspective.胰高血糖素样肽-1 在生殖中的作用：从生理学到治疗学的角度。
Hum Reprod Update. 2019 Jul 1;25(4):504-517. doi: 10.1093/humupd/dmz019.
4
Cross-sectional, case-control and longitudinal associations between exposure to glucagon-like peptide-1 receptor agonists and the dispensing of antidepressants.胰高血糖素样肽-1受体激动剂暴露与抗抑郁药配药之间的横断面、病例对照和纵向关联。
Diabetes Obes Metab. 2024 Jul;26(7):2925-2932. doi: 10.1111/dom.15616. Epub 2024 Apr 23.
5
Perioperative management of long-acting glucagon-like peptide-1 (GLP-1) receptor agonists: concerns for delayed gastric emptying and pulmonary aspiration.长效胰高血糖素样肽-1（GLP-1）受体激动剂的围手术期管理：关注胃排空延迟和肺吸入的问题。
Br J Anaesth. 2024 Apr;132(4):644-648. doi: 10.1016/j.bja.2024.01.001. Epub 2024 Jan 29.
6
The value of short- and long-acting glucagon-like peptide-1 agonists in the management of type 2 diabetes mellitus: experience with exenatide.短效和长效胰高血糖素样肽-1激动剂在2型糖尿病管理中的价值：艾塞那肽的应用经验
Curr Med Res Opin. 2016;32(1):61-76. doi: 10.1185/03007995.2015.1103214. Epub 2015 Nov 11.
7
Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity/Metabolic Syndrome, Prediabetes/Diabetes and Non-Alcoholic Fatty Liver Disease-Current Evidence.胰高血糖素样肽-1受体激动剂及双重葡萄糖依赖性促胰岛素多肽/胰高血糖素样肽-1受体激动剂在肥胖/代谢综合征、糖尿病前期/糖尿病及非酒精性脂肪性肝病治疗中的应用——当前证据
J Cardiovasc Pharmacol Ther. 2022 Jan-Dec;27:10742484221146371. doi: 10.1177/10742484221146371.
8
Do glucagon-like peptide-1 receptor (GLP-1R) agonists have potential as adjuncts in the treatment of type 1 diabetes?胰高血糖素样肽-1 受体 (GLP-1R) 激动剂是否有潜力作为 1 型糖尿病的辅助治疗药物？
Expert Opin Pharmacother. 2018 Oct;19(15):1655-1661. doi: 10.1080/14656566.2018.1519547. Epub 2018 Sep 20.
9
An overview of once-weekly glucagon-like peptide-1 receptor agonists--available efficacy and safety data and perspectives for the future.每周一次胰高血糖素样肽-1 受体激动剂概述——现有疗效和安全性数据及未来展望。
Diabetes Obes Metab. 2011 May;13(5):394-407. doi: 10.1111/j.1463-1326.2011.01357.x. Epub 2011 Jan 5.
10
Blood pressure lowering efficacy of dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 (GIP/GLP-1) receptor agonists compared to glucagon-like peptide-1 (GLP-1) receptor agonists.与胰高血糖素样肽-1（GLP-1）受体激动剂相比，双重葡萄糖依赖性促胰岛素多肽/胰高血糖素样肽-1（GIP/GLP-1）受体激动剂的降压疗效
Cochrane Database Syst Rev. 2025 Apr 16;4(4):CD016144. doi: 10.1002/14651858.CD016144.
引用本文的文献
1
Obesity and male infertility - a tenuous relationship: Facts discerned for the busy clinicians.肥胖与男性不育——一种微妙的关系：为忙碌的临床医生梳理的事实
Arab J Urol. 2025 Mar 5;23(3):169-176. doi: 10.1080/20905998.2025.2473219. eCollection 2025.
本文引用的文献
1
Effects of the glucagon-like peptide-1 receptor agonist dulaglutide on sexuality in healthy men: a randomised, double-blind, placebo-controlled crossover study.胰高血糖素样肽-1 受体激动剂度拉鲁肽对健康男性性功能的影响：一项随机、双盲、安慰剂对照交叉研究。
EBioMedicine. 2024 Sep;107:105284. doi: 10.1016/j.ebiom.2024.105284. Epub 2024 Sep 4.
2
The impact of obesity and metabolic health on male fertility: a systematic review.肥胖和代谢健康对男性生育力的影响：系统评价。
Fertil Steril. 2023 Dec;120(6):1098-1111. doi: 10.1016/j.fertnstert.2023.10.017. Epub 2023 Oct 14.
3
Trends in glucagon-like peptide 1 receptor agonist use, 2014 to 2022.2014 年至 2022 年胰高血糖素样肽-1 受体激动剂使用趋势。
J Am Pharm Assoc (2003). 2024 Jan-Feb;64(1):133-138. doi: 10.1016/j.japh.2023.10.002. Epub 2023 Oct 10.
4
Sexual and Reproductive Outcomes in Obese Fertile Men with Functional Hypogonadism after Treatment with Liraglutide: Preliminary Results.利拉鲁肽治疗后肥胖且伴有功能性性腺功能减退的生育期男性的性与生殖结局：初步结果
J Clin Med. 2023 Jan 14;12(2):672. doi: 10.3390/jcm12020672.
5
Tirzepatide: First Approval.替尔泊肽：首次获批
Drugs. 2022 Jul;82(11):1213-1220. doi: 10.1007/s40265-022-01746-8.
6
Sperm count is increased by diet-induced weight loss and maintained by exercise or GLP-1 analogue treatment: a randomized controlled trial.饮食诱导的体重减轻可增加精子数量，并通过运动或胰高血糖素样肽-1类似物治疗维持：一项随机对照试验。
Hum Reprod. 2022 Jun 30;37(7):1414-1422. doi: 10.1093/humrep/deac096.
7
Human Sperm Express the Receptor for Glucagon-like Peptide-1 (GLP-1), Which Affects Sperm Function and Metabolism.人类精子表达胰高血糖素样肽-1（GLP-1）受体，该受体影响精子功能和代谢。
Endocrinology. 2020 Apr 1;161(4). doi: 10.1210/endocr/bqaa031.
8
The role of glucagon-like peptide-1 in reproduction: from physiology to therapeutic perspective.胰高血糖素样肽-1 在生殖中的作用：从生理学到治疗学的角度。
Hum Reprod Update. 2019 Jul 1;25(4):504-517. doi: 10.1093/humupd/dmz019.
9
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1.胰高血糖素样肽-1 的作用机制与治疗应用。
Cell Metab. 2018 Apr 3;27(4):740-756. doi: 10.1016/j.cmet.2018.03.001.
10
Male fertility and obesity: are ghrelin, leptin and glucagon-like peptide-1 pharmacologically relevant?男性生育能力与肥胖：胃饥饿素、瘦素和胰高血糖素样肽-1在药理学上是否相关？
Curr Pharm Des. 2016;22(7):783-91. doi: 10.2174/1381612822666151209151550.
Zotero 插件